Intuitive Surgical (ISRG) Total Non-Current Liabilities (2009 - 2026)
Intuitive Surgical (ISRG) posted Total Non-Current Liabilities of $1.9 billion for Q2 2026, up 0.62% on a QoQ basis from $1.9 billion in Q1 2026, and up 13.61% year-over-year from $1.7 billion in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Total Non-Current Liabilities for 18 years, with the latest figure at $1.9 billion in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 13.61% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 13.61% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 14.95% from the prior year.
- Total Non-Current Liabilities was $1.9 billion for Q2 2026 at Intuitive Surgical, up from $1.9 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $2.0 billion in Q4 2025, with the low at $1.1 billion in Q1 2022.
- Average Total Non-Current Liabilities over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities soared 35.92% in 2023, then decreased 3.31% in 2024.
- Over 5 years, Total Non-Current Liabilities stood at $1.4 billion in 2022, then gained by 16.64% to $1.7 billion in 2023, then advanced by 5.22% to $1.7 billion in 2024, then rose by 14.95% to $2.0 billion in 2025, then declined by 4.15% to $1.9 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.9 billion (Q2 2026), $1.9 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Bn |
| Mar 31, 2026 | 1.91 Bn |
| Dec 31, 2025 | 2.01 Bn |
| Sep 30, 2025 | 1.80 Bn |
| Jun 30, 2025 | 1.69 Bn |
| Mar 31, 2025 | 1.54 Bn |
| Dec 31, 2024 | 1.75 Bn |
| Sep 30, 2024 | 1.68 Bn |
| Jun 30, 2024 | 1.49 Bn |
| Mar 31, 2024 | 1.38 Bn |
| Dec 31, 2023 | 1.66 Bn |
| Sep 30, 2023 | 1.68 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 1.31 Bn |
| Dec 31, 2022 | 1.42 Bn |
| Sep 30, 2022 | 1.23 Bn |
| Jun 30, 2022 | 1.18 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 1.15 Bn |
| Sep 30, 2021 | 1.03 Bn |